Predicting Cardiovascular Risk Factors for Acute Leukemia Patients by Assessing Subclinical Atherosclerosis and Left Ventricular Function Before Chemotherapy
AL and cardiovascular risk factors interacted before chemotherapy. To decrease cardiotoxicity, AL patients need cardiovascular risk assessment. Subclinical atherosclerosis and echocardiography help chemotherapy patients to choose a treatment regimen, predict long-term outcomes, and predict cardiovascular issues.
Authors
- Elena Constanta Amaricai (ORCID: https://orcid.org/0000-0002-0706-7449)
- Marius Militaru (ORCID: https://orcid.org/0000-0003-3464-5782)
- Anca Maria Cîmpean (ORCID: https://orcid.org/0000-0002-9530-022X)
- Anda Gabriela Militaru (ORCID: https://orcid.org/0000-0001-5455-5341)
- Daniel Lighezan (ORCID: https://orcid.org/0000-0002-5725-8753)
Institutions
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Publication Details
- Journal
- Life
- Published
- 2025-04-27
- DOI
- https://doi.org/10.3390/life15050704
- Citations
- 2
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 2.78